Publications
- Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction2016 | Third Faculty of Medicine, Faculty of Mathematics and Physics
- Mortality in patients with TIMI 3 flow after PCI in relation to time delay to reperfusion2016 | Third Faculty of Medicine
- Efficacy of P2Y12 receptor antagonists in patients with atrial fibrillation according to the CHA2DS2VASc score2016 | Third Faculty of Medicine
- Antiplatelet effect of prasugrel and clopidogrel in hypothermic patients after cardiac arrest for acute myocardial infarction2014 | Third Faculty of Medicine, Faculty of Mathematics and Physics
- Pretreatment with Prasugrel in Non-ST-Segment Elevation Acute Coronary Syndromes2013 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Management of Antiplatelet Therapy in Patients at Risk for Coronary Stent Thrombosis Undergoing Non-Cardiac Surgery2011 | Third Faculty of Medicine
- Optimal pretreatment timing for high load dosing (600 mg) of clopidogrel before planned percutaneous coronary intervention for maximal antiplatelet effectiveness2010 | First Faculty of Medicine, Third Faculty of Medicine
- Antithrombotic therapy in patients at risk for coronary stent thrombosis undergoing non-cardiac surgery2010 | Third Faculty of Medicine
- High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial2009 | First Faculty of Medicine, Third Faculty of Medicine
- The time has come for new, more precise guidelines in the treatment of high-risk acute coronary syndromes with heparin2008 | Third Faculty of Medicine
Loading network view...